Narcolepsy, sleep apnea, hypersomnia and other sleep disorders: new research in plain English.
Two phase 3 trials report strong results for an orexin receptor agonist in narcolepsy type 1. That is exciting, narrow, and not a lesson for ordinary tiredness.
Sep 13, 2026
•
5 min read
